News
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." ...
Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to access life-changing weight loss medications.
Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...
It's a trend ... or untested tirzepatide. The company said it is filing lawsuits, educating consumers and working with social media companies to identify and remove posts that promote unsafe products, ...
A novel artificial intelligence (AI) neural network can track disease progression in idiopathic pulmonary fibrosis (IPF) and identify potential therapies for the disease. The model, developed by ...
Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than patients with cachexia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results